Minoxidil 1% for Eyebrow Enhancement
1 other identifier
interventional
40
1 country
1
Brief Summary
The purpose of the study is to compare efficacy and safety of minoxidil 1% versus placebo in enhancement of eyebrows.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Dec 2013
Shorter than P25 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 13, 2013
CompletedFirst Posted
Study publicly available on registry
August 16, 2013
CompletedStudy Start
First participant enrolled
December 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2014
CompletedApril 22, 2014
April 1, 2014
4 months
August 13, 2013
April 20, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
The change of global photographic assessment after 16 weeks from baseline
baseline and 16 weeks
Secondary Outcomes (1)
The change of hair diameter after 16 weeks from baseline
baseline and 16 weeks
Other Outcomes (3)
The change in number of hairs after 16 weeks from baseline
baseline and 16 weeks
Number of participants with adverse events. Adverse events include any skin rashes or symptoms.
16 weeks
Patient satisfaction by self-assessment questionnaires
baseline and 16 weeks
Study Arms (2)
Minoxidil lotion 1%
EXPERIMENTALMinoxidil lotion 1% is applied twice daily to one eyebrow.
Placebo
PLACEBO COMPARATORPlacebo is applied twice daily to the other eyebrow.
Interventions
Minoxidil lotion 1% is applied twice daily to one eyebrow.
Eligibility Criteria
You may qualify if:
- male or female aged 18-60 years
- hypotrichosis of eyebrows
- healthy
- informed consent obtained
You may not qualify if:
- underlying diseases
- alopecia areata or trichotillomania
- thyroid diseases
- pregnancy or breast feeding
- previous eyebrow tattoo, trauma or accident.
- history of eyebrow or hair medications in 6 months
- history of minoxidil or its ingredient allergy
- history of eyebrow surgery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mae Fah Luang University Hospital (Bangkok)
Bangkok, Thailand
Related Publications (1)
Suwanchatchai W, Tanglertsampan C, Pengsalae N, Makornwattana M. Efficacy and safety of bimatoprost 0.03% versus minoxidil 3% in enhancement of eyebrows: a randomized, double-blind, split-face comparative study. J Dermatol. 2012 Oct;39(10):865-6. doi: 10.1111/j.1346-8138.2012.01579.x. Epub 2012 May 17. No abstract available.
PMID: 22594928RESULT
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
Chuchai Tanglertsampan, MD
Mae Fah Luang University Hospital (Bangkok)
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Instructor
Study Record Dates
First Submitted
August 13, 2013
First Posted
August 16, 2013
Study Start
December 1, 2013
Primary Completion
April 1, 2014
Study Completion
April 1, 2014
Last Updated
April 22, 2014
Record last verified: 2014-04